Intravenous Ketamine in the Treatment of Substance Use Disorder
Chidalu N. Ibeneme, Amarachukwu B. Diala, Victory Afolabi, Nkechinyere M. Harry, Kenechukwu Anona, Vivien O. Obitulata-Ugwu, Olubukola Anike Kuye, Oluwatosin Arubuolawe, Ibrahim Folorunsho, Adeniyi Kayode Busari, Chinelo Madekwe & Soji Ojo · Journal of Advances in Medicine and Medical Research · 2024
Background: Substance use disorders (SUD) represent a critical public health issue, significantly contributing to global morbidity and mortality. Traditional pharmacotherapies for SUD have limited efficacy, necessitating innovative treatment approaches. Ketamine, an N-methyl-D-as...
Open access
Research Article
10.9734/jammr/2024/v36i105596